إعلان
إعلان
GRCE
Grace Therapeutics, Inc. Common Stock
3.71
USDبرعاية
-0.09
-2.50%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
3.83
+0.12
+3.24%
تقارير أرباح GRCE
النسبة الإيجابية المفاجئة
GRCE تفوق 14 من 22 آخر التقديرات.
64%
التقرير التالي
بيانات التقرير القادم
١٣ فبراير ٢٠٢٦
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.28
التغير الضمني من Q2 26 (Revenue/ EPS)
--
/+366.67%
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+7.69%
Grace Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, GRCE reported earnings of -0.06 USD per share (EPS) for Q2 26, beating the estimate of -0.18 USD, resulting in a 68.20% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.31% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 المحللين forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an زيادة of 366.67% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Grace Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Grace Therapeutics, Inc. Common Stock reported EPS of -$0.06, beating estimates by 68.2%, and revenue of $0.00, 0% as expectations.
How did the market react to Grace Therapeutics, Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 2.31%, changed from $3.03 before the earnings release to $3.10 the day after.
When is Grace Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٣ فبراير ٢٠٢٦.
What are the forecasts for Grace Therapeutics, Inc. Common Stock's next earnings report?
Based on 4
المحللين, Grace Therapeutics, Inc. Common Stock is expected to report EPS of -$0.28 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان